MSB 2.08% 94.0¢ mesoblast limited

Ann: MSB Presents at Edison Group Global Healthcare Conference, page-224

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    "particularly in Grade 3 patients . The most accurate classifications have come form ST2 bio marker scores incorporated into the MAGIC algorithms.'

    now you're fudging with the best of them OP. as you and MSB do with data and secondaries....

    answer the fact in your OWN P3 data that Grade B only achieved 50% OR at day 28 - which was your OWN primary.

    "Tripe" was aimed at your airhead breathren Barmaid.
    you get the title of "fudgemaker" with your claims

    I repeat.....

    Going by your own treatment in Japan needing min 8 or up to 12 infusions, the comp did it with 2!, yes only day 0 and days 7.
    vs "twice weekly for 4 weeks min"

    Meso uses 6-12x the number of cells per Kg of bodyweight.

    so lets now acknowledge that the comp may have a less invasive and more potent treatment along with an undeniable lower COGS treatment.


    debate that!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.